drugset / Trial / NCT01161602
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)
Summary
The purpose of this study is to determine if pumosetrag is effective in treating Gastroesophageal Reflux Disease (GERD) symptoms in patients who have a history of GERD symptoms and are currently taking an acid suppression therapy, such as a Proton Pump Inhibitor (PPI).
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pumosetrag | Unknown | 0.2 mg | — |
| Subject | Pumosetrag | Unknown | 0.5 mg | — |
| Subject | Pumosetrag | Unknown | 0.8 mg | — |